RecruitingNCT06490926
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
Studying Atypical progressive supranuclear palsy syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fujian Medical University Union Hospital
- Enrollment
- 180 enrolled
- Eligibility
- 45-80 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06490926 on ClinicalTrials.govOther trials for Atypical progressive supranuclear palsy syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06162013The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical ParkinsonismHaukeland University Hospital
- ACTIVE NOT RECRUITINGNANCT05792332Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGNCT06645626Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian SyndromesUniversity Hospital Southampton NHS Foundation Trust
- RECRUITINGNCT06501469Biomarkers in Parkinsonian SyndromesNon-profit organization for scientific research in Parkinson's disease and related disorders
- RECRUITINGNANCT03174938The Swedish BioFINDER 2 StudySkane University Hospital
See all trials for Atypical progressive supranuclear palsy syndrome →